ACRIN CV Committee ACRIN PDRC ACRIN PA 4008 Protocol and Regulatory Requirements Patricia Atkinson, Quality Control Monitor.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Tips to a Successful Monitoring Visit
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
What is a Data and Safety Monitoring Plan and how do I get one? Presented by Office of Human Research Protection.
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
A Blueprint For Clinical Research: Standard Operating Procedures
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
John Naim, PhD Director Clinical Trials Research Unit
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
Working with Quorum Allina Health Megan Simpson, CIP Senior Study Manager Allina Account Manager.
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Response to FDA Audit 483 MX-4501N : Nine Category 483 Citations Meetings Minutes: Votes for, against, abstention and reason not recorded;
Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
Revised Audit Manual – Fall Meeting 2009 September 30, 2009 REVISED AUDIT MANUAL Chris Steward, ACRIN Quality Control Auditor.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
THE ROLE OF DSMB’s in CLINICAL RESEARCH Data and Safety Monitoring Monitoring.
Andrew Thornton, Chairman, RAH HREC
Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.
RESCUE 4701 Adverse Event Reporting October 16, 2010 Maria Oh, Director Protocol Development & Regulatory Compliance.
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
1 Phidisa: Regulatory and Ethics Operational Team Report Col. Xolani Currie, Chair Laura McNay, Co-Chair Ezekiel Emmanuel Patty Price-Abbott Anita Lessing.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.
Working with The Johns Hopkins University General Clinical Research Center (GCRC)
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
RESIDENT PROJECTS ROBERT LEONHARD QUALITY IMPROVEMENT MANAGER.
How to Successfully Apply to the IRB Richard Gordin, IRB Chair True Rubal, Administrator / Director For the Protection of Human Participants in Research.
IWK Research Ethics - Workshop Series Session #2 REB Review Procedures How to submit … October 24, 2013 Bev White, Manager, Research Ethics Research Services,
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Institutional Review Board Procedures and Implications After the applied dissertation committee has approved the proposal and the IRB package, the student.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
ROAD MAP: Getting a Cancer Study Done at Jefferson Sylvia O’Neill, MD Associate Director of Regulatory Affairs and Quality Assurance Clinical Trials Office.
Investigational Devices and Humanitarian Use Devices June 2007.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
Fully accredited since 2006 Tom Conquergood, CIP Working with Quorum October 13, 2015 Thomas Jefferson University.
Data and Safety Monitoring Board Responsibilities Review routine reports created by ACRIN Biostatistics Center: Mid-Year and Year-End Updates. Routine.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Sponsor Visits and Monitoring
Institutional Review Board Procedures and Implications After the applied dissertation committee has approved the proposal and the IRB package, the student.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Good Clinical Practice (GCP) and Monitoring Practices
Responsibilities of Sponsor, Investigator and Monitor
IRB reporting updates.
What is a Data and Safety Monitoring Plan and how do I get one?
Reportable Events & Other IRB Updates February 2017
Navigating eIRB and eIRB Submission Types
Elements of an Organized Regulatory Binder
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Clinical Trial Development: RA’s Role, OEWG, and IRB Submissions Martha Heckel Protocol Associate, ACRIN Dept. of Protocol Development & Regulatory.
PEARLS Overview and Research Team Management
Quality Assurance in Clinical Trials
Protocol Approval Criteria
Presentation transcript:

ACRIN CV Committee ACRIN PDRC ACRIN PA 4008 Protocol and Regulatory Requirements Patricia Atkinson, Quality Control Monitor

ACRIN CV Committee ACRIN PDRC Meet the Team Maria Oh, Director James Concannon, Protocol Associate Martha Heckel, Protocol Associate Patricia Atkinson, Quality Control Monitor Mary Kelly-Truran, Quality Control Auditor Chris Steward, Quality Control Auditor

ACRIN CV Committee ACRIN PDRC Regulatory Documentation Required for Site Participation  Protocol specific IRB Approval Letter;  IRB-approved, site-specific Informed Consent Form;  IRB Approval Letter (s) for all recruitment materials when required by the site IRB;  IRB Approval Letters for all revised Informed Consent Forms, amendments and annual approvals;  IRB Membership List, if available, or a memo from IRB indicating membership meeting federal regulatory compliance.

ACRIN CV Committee ACRIN PDRC Adverse Event Reporting The site Principal Investigator is responsible for the assignment of grade (severity level) and attribution (causation) of each Adverse Event. (Please review protocol section 10.0 for definitions and details)

ACRIN CV Committee ACRIN PDRC Adverse Event Reporting Routine vs. Expedited reporting:  Routine reporting is defined as documentation of Adverse Events on the ACRIN AE CRF. Once submitted to ACRIN this data will be reported to the Data and Safety Monitoring Committee (DSMC), CDUS, and used in the final study report.  Expedited reporting Expedited reporting is defined as immediate notification of ACRIN within the specified timeframe outlined in the protocol and in Table A (page 31) and completion of the ACRIN SR CRF. Routine reporting requirements also apply(completion of ACRIN AE CRF).

ACRIN CV Committee ACRIN PDRC Adverse Event Reporting  Prompt reporting of AEs is the responsibility of each investigator, clinical RA, and/or nurse engaged in clinical research. Please refer to protocol section 10.0 for specific details about Adverse Events.  ACRIN will collect and report adverse events and serious adverse events per protocol section 10.8 (please review).  Anyone uncertain about whether a particular AE should be reported should contact ACRIN headquarters at for assistance.

ACRIN CV Committee ACRIN PDRC ACRIN Monitoring and Auditing Programs  To ensure study integrity and quality through data verification  To ensure safety and welfare of study participants  Continual assessment and review to ensure accuracy and completeness of study data and compliance through:  Review of Regulatory Requirements;  Review or Protocol Requirements;  Review of Participant Charts.

ACRIN CV Committee ACRIN PDRC ACRIN Monitoring Program  Monitoring at ACRIN consists of a remote review of all regulatory documents and participant chart(s) for source verification of the study data.  Monitoring reviews are implemented at various time points or rounds from initial participant enrollment and throughout the conduct of the trial.  The number of participant charts to be reviewed for each round of monitoring will be determined by:  study design;  the number of participants enrolled at each site;  scientific endpoints.

ACRIN CV Committee ACRIN PDRC ACRIN Auditing Program  Audits will be conducted on site.  The number of participant charts to be reviewed at each audit visit will be determined by the auditor.  The timing of initial on-site audit will depend on several factors including the following:  rate of accrual (both study-wide and site-specific);  the number of evaluable participants enrolled at an individual site;  the status of the protocol and pending amendments;  at least 3 months after an institution has been monitored;  after the number of evaluable participants reaches 30% of targeted accrual, either study-wide and/or site-specific;  closure of the study to accrual;  site-specific circumstances.

ACRIN CV Committee ACRIN PDRC ACRIN Auditing Program  Audits can be conducted more frequently at the discretion of the protocol team;  Subsequent audits will be scheduled per the outcome of the initial audit;  Major discrepancies will be forwarded to the appropriate oversight body within ACRIN;  The ACRIN Audit Manual is available online at

ACRIN CV Committee ACRIN PDRC Questions?

ACRIN CV Committee ACRIN PDRC Thank you!